Fairtility™ is on a mission to transform IVF into a transparent process, delivering unparalleled visibility to both IVF professionals and patients with CHLOE™ (Cultivating Human Life through Optimal Embryos). CHLOE™ is the first and only transparent AI-based decision support tool. CHLOE™ provides clinicians and prospective parents with visibility into the clinical and laboratory data to help improve IVF outcomes.
Fully secure access for remote patient monitoring
Blastocyst prediction accuracy of 96% and 73% prediction accuracy for implantation prediction2
Provides clinicians and patients with visibility into the clinical and laboratory parameters that make up data output to help improve IVF outcomes
Fully automated developmental-stage annotations
Multiple embryo transfer pregnancy prediction
1 In company file
2 H.K. Yelke,1, G. Ozkara2, B. Yuksel3, Y. Kumtepe Colakoglu2, M. Aygun3, A. Brualla4, I. Erlich4, C. Hickman4, S. Selimoglu3, B. Okten3, S. Kahraman3. (2022) Simplifying the complexity of time-lapse decisions with AI: CHLOE (Fairtility) can automatically annotate morphokinetics and predict blastulation (at 30hpi), pregnancy and ongoing clinical pregnancy. ESHRE Annual Meeting, O-007
Chloe explains the biological parameters that contributed to the final outputs because transparency is comprehensibility.
Chloe equips clinicians with the power of AI to work better and faster and make the most informed decisions for their patients.
Working with Chloe has been tremendously inspiring as we get to see the underlying biology that helps us understand which embryo should be prioritized for transfer. The ability to grade embryos and populate data in the EMR, automatically, saves precious time for our embryologists.”